THE DEAL, AT A GLANCE
From the announcementAdvanced NanoTherapies
01What it doesAdvanced NanoTherapies is a Digital Health company focused on Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAdvanced NanoTherapies raised $31M Series B, announced 2026-06-02From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAdvanced NanoTherapies' $31M Series B is a below-median Healthcare & Life Sciences financing in an active funding tape, signaling selective capital formation rather than…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Advanced NanoTherapies · Financing Record
Explore source-linked visual explanations for Advanced NanoTherapies. Unsupported claims are withheld while source review continues.
Record 5132 · Recorded date: 2026-06-02
Explore company records →